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Abstract
Copper(I) and copper(II) complexes were covalently linked to an engineered variant of the transmembrane protein Ferric hydroxa-
mate uptake protein component A (FhuA ΔCVFtev). Copper(I) was incorporated using an N-heterocyclic carbene (NHC) ligand
equipped with a maleimide group on the side arm at the imidazole nitrogen. Copper(II) was attached by coordination to a terpyridyl
ligand. The spacer length was varied in the back of the ligand framework. These biohybrid catalysts were shown to be active in the
Diels–Alder reaction of a chalcone derivative with cyclopentadiene to preferentially give the endo product.
Introduction
So-called artificial metalloenzymes have attracted attention over
the last decade [1-9]. Incorporation of an organometallic
cofactor into proteins offers new possibilities to expand the
reaction repertoire catalyzed by natural enzymes to non-natural
reactions. With this approach man-made metalloproteins as
asymmetric transfer hydrogenases [10,11], Suzukiases [12],
metatheases [13-20], epoxidases [21], Diels–Alderases [22-27]
and others have been reported. The Diels–Alder reaction is a
powerful C–C bond formation reaction, widely used in organic
chemistry, e.g., for the synthesis of natural products [28]. This
reaction is known to be catalyzed by Lewis acids such as a
Cu(II) complex [29]. Additionally, structurally defined cata-
lysts are found to influence the endo/exo ratio as well as the en-
antioselectivity [30]. Artificial Diels–Alderases have also been
reported to show good endo/exo selectivities as well as high en-
antioselectivities in a benchmark reaction of azachalcone with
cyclopentadiene [22-27].
The artificial Diels–Alderases reported so far used soluble pro-
teins, where the binding site of Cu(II) was formed either by site-
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Scheme 1: Syntheses to Cu(I) complex bearing a NHC ligand.
Scheme 2: Synthesis of Cu(II) terpyridyl complexes.
directed mutagenesis [22,23], by incorporation of a suitable
ligand, or copper complex in an apo-protein [24-27]. Here we
report on the use of the robust transmembrane protein Ferric
hydroxamate uptake protein component A (FhuA) as host for
defined Cu(I) NHC or Cu(II) terpyridyl complexes with a male-
imide moiety. By covalently bonding these copper complexes to
the protein artificial Diels–Alderases based on a membrane pro-
tein have been obtained.
Results and Discussion
Synthesis of the metal complexes
As the protein host, the FhuA ΔCVFtev variant of the Ferric
hydroxamate uptake protein component A (FhuA) was chosen
[31]. This protein was shown to be suitable to harbor
Grubbs–Hoveyda type catalysts for olefin metathesis [17,18].
To anchor Cu(I) in the protein FhuA ΔCVFtev that contains a
cysteine residue at position 545 for conjugation [31], an NHC
ligand containing a maleimide function was prepared
(Scheme 1).
The imidazolium salt 3 was synthesized by nucleophilic substi-
tution of mesityl imidazol 1 with maleimide derivative 2. These
salts were used to generate the Cu(I) NHC complexes 4 upon
deprotonation with K2CO3. Complex 4 contains only one NHC
ligand at the copper, as shown by elemental analysis and
ESIMS. Attempts to coordinate Cu(II) to the NHC ligand failed.
However, the terpyridyl (terpy) ligand is a promising candidate
to support Cu(II) ions. Therefore, the terpy framework contain-
ing an alcohol function on the 4 position of the central pyridine
was chosen (Scheme 2).
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Scheme 3: Anchoring and refolding of the biohybrid copper complexes.
By either esterification or nucleophilic attack, the spacer with
the maleimide group was attached. The ligand was treated with
one equivalent of Cu(NO3)2·3H2O leading to the Cu(II) com-
plexes 10–12.
By using the established anchoring strategy, the Cu(I) and
Cu(II) complexes (4 and 10–12) were anchored covalently
inside the β-barrel structure. After anchoring, the protein was
refolded by dialysis (Scheme 3).
Anchoring of all complexes was successful. Titration of the free
cysteine with the fluorescence dye ThioGlo® indicated that
more than 95% of the cysteine residues were conjugated for
each catalyst.
Renaturing of the protein was successful in the case of the terpy
ligand framework (for clarity of the location of the catalyst, see
Figure S1 in Supporting Information File 1). After 3 days of di-
alysis against SDS-solution, excess catalyst 10–12 was re-
moved. Additional 3 days of dialysis against PE-PEG solution
renatured the protein structure to give the expected β-barrel
structure, as indicated by CD spectra (Figure 1).
The CD spectra show a minimum at around 215 nm and a
maximum at 195 nm, as expected for β-barrel proteins such as
FhuA [17,18,31]. This finding suggests correct refolding of the
protein. Additionally, the temperature stability of the new
conjugate 17 was evaluated.
Figure 1: CD spectra of refolded catalysts 17–19 (red: 17, black: 18,
blue: 19).
The temperature-dependent CD spectra indicate correct folding
of the catalyst in the temperature range from 4 °C to 64 °C
(Figure 2). This is in agreement with previously reported
stability analysis of the wild-type FhuA and the FhuA mutant
with its “cork” domain removed (FhuA Δ1-159) [31].
The Cu(I) NHC-containing protein could not be renatured. We
speculate that during the refolding procedure Cu(I) was
oxidized to Cu(II) by contamination with air. Cu(II) led to pro-
tein aggregation and precipitation. This was shown in an inde-
pendent experiment. When one equiv of Cu(NO3)2·3H2O was
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Figure 2: Temperature-dependent CD spectra of catalyst 17.
added to a solution of FhuA ΔCVFtev, the protein precipitated
rapidly and quantitatively.
MALDI–TOF–MS analysis for the whole biohybrid catalyst
was difficult due to the high mass of approximately 64 kDa.
However, digestion into smaller fragments is possible with the
deliberately introduced TEV cleavage site [17,18]. The frag-
ment containing the Cu complex was cut out and analyzed sepa-
rately (Figure 3).
Figure 3: MALDI–TOF mass spectra (black: 17, red: FhuAΔCVFtev).
Digestion of biohybrid catalyst 17 was successful. Comparison
of the MALDI–TOF– MS spectrum with FhuA ΔCVFtev (calcd
(M + Na+): m/z = 5925 Da; found: m/z = 5925 Da) indicates
successful coupling. The signal of m/z = 6301 Da indicates the
FhuA fragment with the attached ligand framework (calcd (M):
m/z = 6302 Da; found: m/z = 6301 Da). The signal of
m/z = 6111 Da results from saponification of the ester and the
maleimide moiety (calcd (M + H2O + Na+): m/z = 6111 Da,
found: m/z = 6111 Da). We were unable to detect the copper ion
in the MALDI–TOF–MS.
The isolated biohybrid catalysts were tested in the Diels–Alder
reaction of azachalcone 20 and cyclopentadiene (21, Table 1).
We evaluated first the background reaction of this Diels–Alder
reaction in the detergents and buffer solutions we used for the
biohybrid catalysts. Since SDS precipitates at 4 °C and the solu-
tion becomes heterogeneous, we decided to perform the reac-
tions in SDS at 23 °C. After 3 days, the reaction showed
62% conversion with an endo to exo ratio of 70:30 (Table 1,
entry 2). Since detergents such as SDS influences the reaction
significantly, this value is in good agreement with previously
reported results [32]. In PE-PEG at 4 °C the conversion was
lower; the endo/exo ratio was ca. 55:45 (Table 1, entry 1).
Using CuI in SDS, the conversion increased slightly, showing
the same selectivity (Table 1, entry 5). When using Cu(II) as a
catalyst, the conversion was complete in both detergent solu-
tions, but no change in selectivity was observed (Table 1,
entries 3 and 4). CuI NHC complex 4 showed the same activity
and selectivity as CuI (Table 1, entry 6). By using the bioconju-
gate 13, the conversion with 62% is comparable with the pro-
tein-free catalysts or CuI itself, but the selectivity significantly
changed the endo product preferred (Table 1, entry 7). By using
the Cu(II) complexes 10–12 in the refolding buffer: the conver-
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Table 1: Diels–Alder reaction catalyzed by the biohybrid catalysts.
Entry Catalyst Buffer Temp. [°C] Conv.a [%] endo/exob
1 – PE-PEGc 4 20 55/45
2 – SDSd 23 62 70/30
3 Cu(NO3)2·3H2O PE-PEGc 4 95 54/46
4 Cu(NO3)2·3H2O SDSd 23 94 65/35
5 CuI SDSd 23 78 70/30
6 4 SDSd 23 75 67/33
7 13 SDSd 23 62 90/10
8 10 PE-PEGc 4 21 65/35
9 11 PE-PEGc 4 33 56/44
10 12 PE-PEGc 4 12 66/34
11 14 SDSd 23 92 90/10
12 15 SDSd 23 87 89/11
13 16 SDSd 23 91 89/11
14 17 PE-PEGc 4 69 96/4
15 18 PE-PEGc 4 15 66/34
16 19 PE-PEGc 4 64 98/2
aDetermined by 1H NMR in CDCl3 and HPLC. bDetermined by HPLC. cPE-PEG (0.125 M), sodium phosphate buffer (100 mM, pH 7.4).
dSDS (1% w/w), pH 7.5 (adjusted with NaHCO3).
sion decreased with an endo/exo ratio of approximately 60/40
(Table 1, entry 8–10). Upon attaching the catalyst to the protein
in the partially folded state, the selectivity increased to
90% endo with high conversions independent of the spacer
length (Table 1, entry 11–13). The refolded biohybrid catalysts
17 and 19 showed good conversion with almost quantitative
endo product formation (Table 1, entries 14 and 16). Catalyst 18
with the longest spacer unit, however, showed moderate activi-
ty and loss of endo selectivity. This is explained by the high
flexibility of this catalyst within the β-barrel structure of the
refolded protein (Table 1, entry 15). Based on these catalysis
results, we hypothesize that the protein environment is steri-
cally rather demanding, which is even more pronounced in the
refolded state. The absence of any enantioselectivity suggests
that no preferential orientation of the substrate at the active site
within the barrel structure is possible. Notably, no protein pre-
cipitated during catalysis, showing the advantageous feature of
membrane proteins in terms of robustness as compared to
soluble proteins [15].
Conclusion
Herein, we report the synthesis of Cu(I) NHC and Cu(II)
terpyridyl complexes equipped with a maleimide moiety
which underwent covalent conjugation at the cysteine
residue 545 of the transmembrane protein FhuAΔCVFtev.
These biohybrid conjugates were analyzed by CD spectros-
copy, MALDI–TOF–MS, ThioGlo fluorescence titration,
and BCA assay. All employed methods indicate the folded
structure of  FhuA ΔCVF t ev  and a high occupancy
of the only accessible cysteine residue within this β-barrel
protein.
The biohybrid catalysts showed high activity and high endo
selectivity in the Diels–Alder reaction of substrate 20 with
cyclopentadiene (21). A comparison with other reported artifi-
cial Diels–Alderases is not meaningful because of the utiliza-
tion of detergents in the present case, which increases the
stability towards the Diels–Alder reaction conditions. However,
similar trends with respect to both activity and endo selectivity
were observed. The cavity of FhuA appears to enhance the
reaction as reported by Hayashi et al. for nitrobindin [26],
Reetz et al. for serum albumin [22,23], and Roelfes et al.
for Lactococcal multidrug resistance Regulator (LmrR)
[25]. Furthermore, the increased endo selectivity is in
agreement with other protein-modified catalysts reported so far
[22-27].
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Experimental
General considerations
All manipulations were performed under argon atmosphere
using standard Schlenk or glove box techniques. Prior to use,
glassware was dried overnight at 130 °C and solvents were
dried, distilled and degassed using standard methods. Catalysis
with Cu(II) complexes were performed under ambient condi-
tions. NMR measurements were performed on a Bruker Avance
II 400 or a Bruker Avance III HD 400 spectrometer at ambient
temperature unless otherwise mentioned. The chemical shifts
(δ ppm) in the 1H and 13C NMR spectra were referenced to the
residual proton signals of the deuterated solvents and reported
relative to tetramethylsilane [33]. Abbreviations for NMR spec-
tra: s (singlet), d (doublet), t (triplet), quint (quintet), m (multi-
plet). Elemental analyses were performed on an elementar vario
EL machine. CD spectra were recorded on a JASCO J-1100
equipped with a single position Peltier cell  holder.
MALDI–TOF spectra were recorded on an Ultraflex III TOF/
TOF mass spectrometer (Bruker Daltonics). High resolution
ESI–TOF–MS were performed on a Thermo Finnigan LCQ
Deca XP Plus spectrometer. CuI and Cu(NO3)2·3H2O were pur-
chased from Sigma-Aldrich and used as recieved. Cyclopenta-
diene was freshly distilled before used. Compounds 1 [34], 2
[35], 5 [36], 6 [37], 7 [37], 12 [26], 20 [32] and FhuAΔCVFtev
[17] were synthesized according to literature procedures.
Syntheses
Synthesis and characterization of IMesBr 3
A solution of 1-(3-bromopropyl)-1H-pyrrol-2,5-dione (1.69 g,
7.75 mmol, 1.00 equiv) and 1-(mesityl)-1H-imidazole (1.66 g,
8.91 mmol, 1.10 equiv) in toluene (35 mL) was stirred in a
closed Schlenk tube for 24 h at 110 °C. The colorless precipi-
tate was filtered, washed with toluene (3 × 15 mL) and dried
under vacuum to afford analytically pure imidazolium salt 1
(2.58 g, 6.40 mmol, 83%) as colorless powder. 1H NMR
(400 MHz, CD2Cl2) δ 10.32 (s, 1H, NCHN), 8.07 (s, 1H,
CH=CH), 7.28 (s, 1H, CH=CH), 7.05 (s, 2H, aryl CH), 6.73 (s,
2H, CH=CH), 4.68 (t, 3JHH = 6.85 Hz, 2H, CH2), 3.58 (t, 3JHH
= 6.42 Hz, 2H, CH2), 2.35 (s, 3H, p-CH3), 2.34 (quint,
3JHH = 6.72 Hz, 2H, CH2), 2.10 (s, 6H, o-Me); 13C NMR (100
MHz, CD2Cl2) δ 171.5 (C=O), 141.9, 139.0 (NCHN), 135.0
(CH=CH), 134.9, 131.3, 130.2, 123.8 (CH=CH), 123.7, 48.0
(CH2), 34.5 (CH2), 30.2 (CH2), 21.4 (p-Me), 18.0 (o-Me);
ESIMS (+) m/z (%): calcd for (C19H22N3O2)+, 324.171; found,
324.170 (100).
Synthesis and characterization of NHC-Cu(I)I
complex 4
The Imidazolium salt 3 (200 mg, 0.495 mmol, 1.00 equiv),
K2CO3 (280 mg, 2.02 mmol, 4.00 equiv) and CuI (95 mg,
0.495 mmol, 1.00 equiv) was stirred in THF (5 mL) for 24 h at
23 °C. The solvent was evaporated under vacuum and the
residue was dissolved in dichloromethane (4 mL). After
filtering over Celite® the solvent was evaporated under vacuum
and the residue dried under vacuum to afford CuI NHC com-
plex 6 (150 mg, 0.292 mmol, 59%) as orange powder. 1H NMR
(400 MHz, CDCl3) δ 7.19 (s, 1H, CH=CH), 7.28 (s, 1H,
CH=CH), 6.93 (s, 2H, aryl CH), 6.83 (s, 2H, CH=CH), 4.21 (t,
3JHH = 6.72 Hz, 2H, CH2), 3.58 (t, 3JHH = 6.72 Hz, 2H, CH2),
2.31 (s, 3H, p-Me), 2.16 (quint, 3JHH = 6.72 Hz, 2H, CH2), 2.00
(s, 6H, o-Me); 13C NMR (100 MHz, CDCl3,) δ 181.7 (NCN),
170.6 (C=O), 139.0, 135.4, 134.9, 134.2, 129.1 121.7, 120.6,
48.3 (CH2), 34.7 (CH2), 30.5 (CH2), 21.0 (p-Me), 17.9 (o-Me);
Anal. calcd for C19H21CuIN3O2, C, 44.41; H, 4.36; N, 8.18;
found: C, 44.02; H, 4.01; N, 7.75; ESIMS (+) m/z (%): calcd for
(C19H21CuN3O2)+ 388.092; found, 388.106 (100).
Synthesis of terpyridyl ligands 8 and 9
A solution of terpyridine 5 (200 mg, 0.803 mmol, 1.00 equiv) in
THF (10 mL) was treated with acid chloride 6 (165 mg,
0.884 mmol, 1.10 equiv) or 7 (177 mg, 0.884 mmol, 1.10 equiv)
in THF (5 mL). Triethylamine (NEt3) (222 µL, 1.61 mmol,
2.00 equiv) was added to the solution and the mixture was
stirred for 16 h at 23 °C. The solution was filtered and all vola-
tiles evaporated. The residue was dissolved in dichloromethane
(50 mL), washed twice with water (50 mL), and once with brine
(50 mL). The organic layer was dried over Na2SO4 and the sol-
vent removed under vacuum affording the terpyridine ligand 8
(285 mg, 0.715 mmol, 89%) or 9 (280 mg, 0.699 mmol, 87%).
1H NMR (8, 400 MHz, CD2Cl2) δ 8.69 (m, 2H, aryl CH), 8.60
(dt, 3JHH = 8.0 Hz, 3JHH = 1.0 Hz, 2H, aryl CH), 8.26 (s, 2H,
aryl CH), 7.86 (m, 2H, aryl CH), 7.34 (ddd, 3JHH = 7.4 Hz,
3JHH = 4.8 Hz, 3JHH = 1.1 Hz, 2H, aryl CH), 6.75 (s, 2H,
HC=CH), 4.00 (t, 3JHH = 7.0 Hz, 2H, CH2), 2.99 (t,
3JHH = 7.0 Hz, 2H, CH2) ppm; 1H NMR (9, 400 MHz, CD2Cl2)
δ  8.69 (m, 2H, aryl CH),  8.61 (dt, 3JHH  = 7.8 Hz,
3JHH = 1.1 Hz, 2H, aryl CH), 8.25 (s, 2H, aryl CH), 7.85 (m,
2H, aryl CH), 7.34 (ddd, 3JHH = 7.4 Hz, 3JHH = 4.9 Hz, 3JHH =
1.0 Hz, 2H, aryl CH), 6.75 (s, 2H, HC=CH), 3.71 (t, 3JHH = 6.8
Hz, 2H, CH2), 2.67 (t, 3JHH = 7.4 Hz, 2H, CH2), 2.09 (pent,
3JHH = 7.2 Hz, 2H, CH2) ppm.
Synthesis of Cu(II)-terpyridine complexes 10 and 11
To a solution of terpyridine ligand 8 (200 mg, 0.500 mmol,
1.00 equiv) or 9 (207 mg, 0.500 mmol, 1.00 equiv) in ethanol
(10 mL), Cu(NO3)2·3H2O (120 mg, 0.500 mmol, 1.00 equiv) in
ethanol was added. The solution was stirred for 2 h at 23 °C.
The blue precipitate was collected and washed generously with
cold THF (20 mL), cold ethanol (50 mL) and cold dichloro-
methane (10 mL). The residue was dried under vacuum, to give
the copper complex 10 (214 mg, 0.365 mmol, 73%) or 11
(207 mg, 0.345 mmol, 69%). ESIMS (10) (+) m/z (%): calcd for
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(C22H16CuN4O4)+, 463.0468; found, 463.0459 (35); calcd for:
(C15H10CuN3O)+, 311.0125; found, 311.0118 (43); ESIMS
(11) (+) m/z (%): calcd for (C23H18CuN4O4)+, 477.0624; found,
477.0624 (7); calcd for (C15H10CuN3O)+; 311.0125; found:
311.0114 (36).
General procedure: Conjugation of the
catalysts to FhuAΔCVFtev and refolding
To a degassed solution of FhuAΔCVFtev in water (5 mg/mL,
pH ≈ 8 (NaHCO3)) containing 1% (w/w) SDS, 10 equiv of cata-
lyst 4 in degassed THF (10% (v/v)) or 10 equiv of catalyst 10,
11, 12 in water (10% (v/v)) was added. The solution was
allowed to stir 16 h.
In the case of catalyst 4, water was removed in vacuum, and the
residue was washed with degassed THF (4 × 15 mL) to remove
excess of catalyst 4. The residue was dried in vacuum and dis-
solved in water.
In the case of catalyst 10–12, the solution was transferred into a
dialysis tube and the solution was dialyzed for 3 days against
200 fold volume containing SDS (1% (w/w)) and water (pH ≈ 8
(NaHCO3)). The dialysis solution was changed every 12 hours.
Afterwards, the sample was dialyzed for 2 days against 200 fold
volume containing the refolding detergent PE-PEG (0.125 mM,
average Mn = 2250 g/mol), sodium phosphate buffer (10 mM,
pH 7.4), and water. The dialysis solution was changed every
12 h.
The protein concentration was analyzed by BCA assay, the cou-
pling efficiency was determined by ThioGlo fluorescence titra-
tion, and correct refolding was determined by CD spectroscopy,
as previously reported [17,18]. Digestion of the proteins was
performed as previously reported [17].
General procedure: Diels–Alder reaction
To the corresponding catalyst (1 mol %) in 2 mL of buffer solu-
tion (0.125 mM PE-PEG, sodium phosphate buffer (100 mM,
pH 7.4), 1 mM EDTA) at 4 °C or 23 °C azachalcone 20 (4 mg,
0.02 mmol) in THF (10% (v/v)) and freshly distilled cyclopen-
tadiene (40 µL, 50 µM, 33 equiv) was added subsequently. The
reaction mixture was stirred for 72 h. Afterwards, the mixture
was extracted with Et2O (3 × 10 mL), the combined organic
phases were dried over Na2SO4 and the solvent removed under
reduced pressure. The residue was analyzed by 1H NMR spec-
troscopy and chiral phase HPLC using heptane/isopropanol
(98:2) as eluents. All reactions were carried out in triplicates.
Abbreviations
PE-PEG (polye thylene-polye thylene  g lycol ) ,  SDS
(sodium dodecyl sulfate), TEV (Tobacco Etch Virus),
MALDI–TOF–MS (matrix-assisted laser desorption/ionisation
and time-of-flight mass spectrometry), FhuAΔCVFtev (FhuA
Δ1-159_C545_V548_F501_tev), CD (circular dichroism), ESI-
MS (electrospray ionization-mass spectrometry), NaPi (sodium
phosphate buffer).
Supporting Information
Supporting Information File 1
Illustration of the catalyst 2 and NMR spectra of
synthesized compounds.
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Acknowledgements
We gratefully acknowledge the financial support by the
Deutsche Forschungsgemeinschaft (DFG) through the Interna-
tional Research Training Group “Selectivity in Chemo- and
Biocatalysis” (SeleCa), the excellence cluster “Tailor-made
Fuels from Biomass” (TMFB), the JSPS Japan-German Grad-
uate Externship Program, and Grants-in-Aid for Scientific
Research (JSPS KAKENHI Grant Number JP15H05804 in
Precisely Designed Catalysts with Customized Scaffolding)
from MEXT.
References
1. Lu, Y. Angew. Chem., Int. Ed. 2006, 45, 5588–5601.
doi:10.1002/anie.200600168
2. Steinreiber, J.; Ward, T. R. Coord. Chem. Rev. 2008, 252, 751–766.
doi:10.1016/j.ccr.2007.09.016
3. Reetz, M. T. Chem. Rec. 2012, 12, 391–406.
doi:10.1002/tcr.201100043
4. Lewis, J. C. ACS Catal. 2013, 3, 2954–2975. doi:10.1021/cs400806a
5. Matsuo, T.; Hirota, S. Bioorg. Med. Chem. 2014, 22, 5638–5656.
doi:10.1016/j.bmc.2014.06.021
6. Hayashi, T.; Sano, Y.; Onoda, A. Isr. J. Chem. 2015, 55, 76–84.
doi:10.1002/ijch.201400123
7. Heinisch, T.; Ward, T. R. Eur. J. Inorg. Chem. 2015, 2015, 3406–3418.
doi:10.1002/ejic.201500408
8. Lu, Y.; Yeung, N.; Sieracki, N.; Marshall, N. M. Nature 2009, 460,
855–862. doi:10.1038/nature08304
9. Yu, F.; Cangelosi, V. M.; Zastrow, M. L.; Tegoni, M.; Plegaria, J. S.;
Tebo, A. G.; Mocny, C. S.; Ruckthong, L.; Qayyum, H.; Pecoraro, V. L.
Chem. Rev. 2014, 114, 3495–3578. doi:10.1021/cr400458x
10. Letondor, C.; Pordea, A.; Humbert, N.; Ivanova, A.; Mazurek, S.;
Novic, M.; Ward, T. R. J. Am. Chem. Soc. 2006, 128, 8320–8328.
doi:10.1021/ja061580o
11. Zimbron, J. M.; Heinisch, T.; Schmid, M.; Hamels, D.; Nogueira, E. S.;
Schirmer, T.; Ward, T. R. J. Am. Chem. Soc. 2013, 135, 5384–5388.
doi:10.1021/ja309974s
12. Chatterjee, A.; Mallin, H.; Klehr, J.; Vallapurackal, J.; Finke, A. D.;
Vera, L.; Marsh, M.; Ward, T. R. Chem. Sci. 2016, 7, 673–677.
doi:10.1039/C5SC03116H
Beilstein J. Org. Chem. 2016, 12, 1314–1321.
1321
13. Lo, C.; Ringenberg, M. R.; Gnandt, D.; Wilson, Y.; Ward, T. R.
Chem. Commun. 2011, 47, 12065–12067. doi:10.1039/c1cc15004a
14. Mayer, C.; Gillingham, D. G.; Ward, T. R.; Hilvert, D. Chem. Commun.
2011, 47, 12068–12070. doi:10.1039/c1cc15005g
15. Matsuo, T.; Imai, C.; Yoshida, T.; Saito, T.; Hayashi, T.; Hirota, S.
Chem. Commun. 2012, 48, 1662–1664. doi:10.1039/c2cc16898g
16. Basauri-Molina, M.; Verhoeven, D. G. A.; van Schaik, A. J.; Kleijn, H.;
Klein Gebbink, R. J. M. Chem. – Eur. J. 2015, 21, 15676–15685.
doi:10.1002/chem.201502381
17. Philippart, F.; Arlt, M.; Gotzen, S.; Tenne, S.-J.; Bocola, M.;
Chen, H.-H.; Zhu, L.; Schwaneberg, U.; Okuda, J. Chem. – Eur. J.
2013, 19, 13865–13871. doi:10.1002/chem.201301515
18. Sauer, D. F.; Bocola, M.; Broglia, C.; Arlt, M.; Zhu, L.-L.; Brocker, M.;
Schwaneberg, U.; Okuda, J. Chem. – Asian J. 2015, 10, 177–182.
doi:10.1002/asia.201403005
19. Sauer, D. F.; Himiyama, T.; Tachikawa, K.; Fukumoto, K.; Onoda, A.;
Mizohata, E.; Inoue, T.; Bocola, M.; Schwaneberg, U.; Hayashi, T.;
Okuda, J. ACS Catal. 2015, 5, 7519–7522.
doi:10.1021/acscatal.5b01792
20. Zhao, J.; Kajetanowicz, A.; Ward, T. R. Org. Biomol. Chem. 2015, 13,
5652–5655. doi:10.1039/C5OB00428D
21. Zhang, C.; Srivastava, P.; Ellis-Guardiola, K.; Lewis, J. C. Tetrahedron
2014, 70, 4245–4249. doi:10.1016/j.tet.2014.03.008
22. Reetz, M. T.; Jiao, N. Angew. Chem., Int. Ed. 2006, 45, 2416–2419.
doi:10.1002/anie.200504561
23. Podtetenieff, J.; Taglieber, A.; Bill, E.; Reijerse, E. J.; Reetz, M. T.
Angew. Chem., Int. Ed. 2010, 49, 5151–5155.
doi:10.1002/anie.201002106
24. Deuss, P. J.; Popa, G.; Slawin, A. M. Z.; Laan, W.; Kamer, P. C. J.
ChemCatChem 2013, 5, 1184–1191. doi:10.1002/cctc.201200671
25. Bos, J.; Fusetti, F.; Driessen, A. J. M.; Roelfes, G.
Angew. Chem., Int. Ed. 2012, 51, 7472–7475.
doi:10.1002/anie.201202070
26. Himiyama, T.; Sauer, D. F.; Onoda, A.; Spaniol, T. P.; Okuda, J.;
Hayashi, T. J. Inorg. Biochem. 2016, 158, 55–61.
doi:10.1016/j.jinorgbio.2015.12.026
27. Ghattas, W.; Cotchico-Alonso, L.; Maréchal, J.-D.; Urvoas, A.;
Rousseau, M.; Mahy, J.-P.; Ricoux, R. ChemBioChem 2016, 17,
433–440. doi:10.1002/cbic.201500445
28. Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G.
Angew. Chem., Int. Ed. 2002, 41, 1668–1698.
doi:10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO
;2-Z
29. Reymond, S.; Cossy, J. Chem. Rev. 2008, 108, 5359–5406.
doi:10.1021/cr078346g
30. Kagan, H. B.; Riant, O. Chem. Rev. 1992, 92, 1007–1019.
doi:10.1021/cr00013a013
31. Tenne, S.-J.; Schwaneberg, U. Int. J. Mol. Sci. 2012, 13, 2459–2471.
doi:10.3390/ijms13022459
32. Otto, S.; Engberts, J. B. F. N.; Kwak, J. C. T. J. Am. Chem. Soc. 1998,
120, 9517–9525. doi:10.1021/ja9816537
33. Fulmer, G. R.; Miller, A. J. M.; Sherden, N. H.; Gottlieb, H. E.;
Nudelman, A.; Stoltz, B. M.; Bercaw, J. E.; Goldberg, K. I.
Organometallics 2010, 29, 2176–2179. doi:10.1021/om100106e
34. Occhipinti, G.; Jensen, V. R.; Törnroos, K. W.; Frøystein, N. Å.;
Bjørsvik, H.-R. Tetrahedron 2009, 65, 7186–7194.
doi:10.1016/j.tet.2009.05.095
35. Perera, A. S.; Subbaiyan, N. K.; Kalita, M.; Wendel, S. O.;
Samarakoon, T. N.; D’Souza, F.; Bossmann, S. H. J. Am. Chem. Soc.
2013, 135, 6842–6845. doi:10.1021/ja403090x
36. Constable, E. C.; Ward, M. D. Dalton Trans. 1990, 1405–1409.
doi:10.1039/DT9900001405
37. de Figueiredo, R. M.; Oczipka, P.; Fröhlich, R.; Christmann, M.
Synthesis 2008, 1316–1318. doi:10.1055/s-2008-1032016
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
(http://www.beilstein-journals.org/bjoc)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjoc.12.124
